Page 26 - Cll News Today

Geoff Grubbs, who was diagnosed with chronic lymphocytic leukemia in 2009, has undergone five lines of treatment and participated in two clinical trials.

The FDA has granted clearance for a global, registrational, phase 3 study examining lisaftoclax in combination with a BTK inhibitor in patients with relapsed/refractory chronic lymphocytic leukemia or small lymphocytic lymphoma who received prior treatment with a BTK inhibitor.

Coverage from the July 25, 2023, session of the Institute for Value-Based Medicine®, held in partnership with Emory's Winship Cancer Institute.

Prioty Islam, MD, MSc, discusses findings from the BRUIN trial, highlights the potential benefits of using noncovalent BTK inhibitors instead of or before covalent BTK inhibitors in patients with MCL or CLL, and previewed ongoing clinical trials investigating this class of agents in earlier treatment lines in these populations.

After being told, "You're not that bad" my whole life, I continued to hear that after being diagnosed with leukemia — which some called "the best" cancer to have.

Fleet Of 50 New CNG Bus: All buses will be equipped with GPS based Automatic Vehicle Location System (AVLS) connected with Central Control and Command Center for real time monitoring of bus operations. Automatic alert generation and redressal for various city functions like route deviation, schedule adherence system/trip miss system for buses, speed violation are likely to be implemented in its entirely with upgradation of BCLL IT this year.

Dr. Hill and Dr. Gia discuss treatment options for patients who progress on covalent and noncovalent BTK inhibitors.

Exploring molecular mechanisms of resistance to BTK inhibitors as well as emergent data concerning how this resistance might be overcome.

Subject-matter experts review treatment options for patients with relapsed/refractory CLL.

CAR T-cell therapy positively benefitted patients with patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).